4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer
- 1 January 1990
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (S5) , 55-61
- https://doi.org/10.1002/ijc.2910460708
Abstract
Breast cancer cells are derived from epithelial cells lining the ducts of the breast. One of the fundamental characteristics that distinguish tumour cells from normal cells is that cancer cells grow in an apparently unregulated way. Understanding the mechanisms that regulate the growth and differentiation of normal breast epithelial cells and the differences between these systems in cancer cells is one of the central goals of research into the cell biology of breast cancer.Keywords
This publication has 50 references indexed in Scilit:
- HER2/neu AMPLIFICATION AND COMEDO TYPE BREAST CARCINOMAThe Lancet, 1989
- Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogeneCell, 1989
- Epidermal and transforming growth factor α in patients with breast tumoursBritish Journal of Cancer, 1989
- An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinomaBritish Journal of Cancer, 1988
- Transforming growth factor αCell, 1988
- Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional SignificanceMolecular Endocrinology, 1988
- Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodiesCell, 1988
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Autophosphorylation sites on the epidermal growth factor receptorNature, 1984